
RK Pharma: Innovating healthcare with quality pharmaceutical ingredients and generic products.
Founded with a mission to innovate healthcare, RK Pharma specializes in the development and manufacturing of high-quality pharmaceutical ingredients and generic products. The company aims to address formulation challenges and provide affordable medication options. Their product lineup includes diclofenac potassium tablets, mycophenolic acid DR tablets, and mitomycin injection vials, among others. RK Pharma focuses on the healthcare market, particularly on products that require unique formulation solutions.
RK Pharma has established itself as a significant player in the pharmaceutical industry through its integrated development, regulatory, and manufacturing capabilities. The company collaborates with various drug product partnerships to enhance its market reach. Notable achievements include the successful commercialization of several complex generic medications. By providing cost-effective and high-quality pharmaceutical solutions, RK Pharma has made a substantial impact on improving patient access to essential medications.

Solaris Pharma
solaris-pharma.com

Kukje Pharma Co.

Meitheal Pharmaceuticals
meithealpharma.com

Dawah Pharmaceuticals
dawahpharma.com

Bionpharma
bionpharma.com

Three Rivers Pharmaceuticals

Qilu Pharmaceutical Co.

Pharco Pharmaceuticals
pharco.org

Pyros Pharmaceuticals
pyrospharma.com

Rjs Biologics

Pharmstandard

Leading Pharma
leadingpharma.com

Dexcel Pharma
dexcel.com

Saptalis Pharmaceuticals

Moksha8
moksha8.com
Companies similar to R K Pharma include Solaris Pharma, Kukje Pharma Co., Meitheal Pharmaceuticals and Dawah Pharmaceuticals.
R K Pharma was founded in 2018.
R K Pharma's headquarters is located in Pearl River, NY, US.
R K Pharma's most recent funding round was for $200M (USD) in June 2023.
As of Jun 6, 2023, R K Pharma has raised a total of $200M (USD).
R K Pharma has 1,001 employees as of Feb 4, 2024.